First Alphabet - Search News

Alphabet, ai and Isomorphic Labs

Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue on its mission to create new drugs and medicines using AI.

Wall Street Journal · 1d

Alphabet-Backed Isomorphic Labs Raises $600 Million for AI Drug Development

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

Bloomberg on MSN · 1d

Alphabet’s AI Drug Unit Raises $600 Million From OpenAI Backer

Isomorphic Labs, the Alphabet Inc.-owned company that uses artificial intelligence to discover drugs, has raised $600 million, the first time it’s taken in external funding.

ETF Daily News2d

First Financial Bankshares Inc Trims Stake in Alphabet Inc. (NASDAQ:GOOGL)

First Financial Bankshares Inc’s holdings in Alphabet were worth $77,448,000 as of its most recent filing with the Securities and Exchange Commission. Several other hedge funds also recently ...

Barron's11mon

Alphabet Launches First-Ever Dividend, Sets $70B Stock Buyback Plan

Alphabet ended the quarter with $108 billion in cash, securities and short-term investments. Aided by a strong first-quarter earnings report, Alphabet shares have soared 16% in late trading to ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Alphabet, ai and Isomorphic Labs

Trending now